June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Erman Akkus Summarizes 5-year Results of CheckMate 040
May 24, 2024, 13:24

Erman Akkus Summarizes 5-year Results of CheckMate 040

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:

“Nivolumab plus ipilimumab after sorafenib in patients with advanced HCC
5-year results of CheckMate 040
Annals of Oncology

Nivolumab 1 mg/kg plus ipilimumab 3 mg/kg Q3W (four doses), followed by nivolumab 240 mg Q2W

  • ORR: 34%
  • mDOR: 51.2 mo
  • mOS: 22.2 mo
  • 60-month OS rate: 29%″

Erman Akkus

Read the article.
Source: Erman Akkus/X
.